Overexpression of ROR2 in osteosarcoma [40], melanoma [44] and breast cancer [45] has been proposed to play a role in cell migration, cell proliferation and spatiotemporal control of tumor cell heterogeneity [46]. Here, ROR2 is linked to osteosarcoma.